A NASA spacecraft is stuffed with so much asteroid rubble from this week’s grab that it’s jammed open and precious particles are drifting away in space, scientists said Friday.Scientists announced the news three days after the spacecraft named Osiris-Rex briefly touched asteroid Bennu 321 million kilometers (200 million miles) away.The mission’s lead scientist, Dante Lauretta, said Tuesday’s operation collected far more material than expected for return to Earth — in the hundreds of grams. The sample container on the end of the robot arm penetrated so deeply into the asteroid …

Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates. Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study volunteer develop a serious health issue, requiring a review of safety data. The two coronavirus vaccines are among several candidates in final-stage testing, the last step before seeking regulatory approval. The drugmakers said they got the go-ahead Friday from the Food and Drug Administration to restart tests in the …

Noting the world is at a critical juncture in the COVID-19 pandemic, the World Health Organization is urging nations to take immediate action to prevent unnecessary deaths, the collapse of essential health systems and the shutdown of economies. Speaking at the agency’s headquarters in Geneva, WHO Director-General Tedros Adhanom Ghebreyesus said too many countries, particularly in the northern hemisphere, are seeing an exponential increase in COVID-19 cases forcing hospitals and intensive care units to run near or above capacity. He called on governments to take key actions immediately to prevent the crisis …

German Health Minister Jens Spahn says he expects a viable vaccine to be available to Germans by early next year and enough for “a large number of those want to be vaccinated” within six or seven months. In an interview published Friday in Germany’s Der Spiegel, Spahn — who tested positive for COVID-19 this week — said he expects there would be more than enough vaccine for the German population, and he would like to pass on any surplus to other nations that might need it. FILE – German Health Minister Jens …

Belgian officials Friday announced new COVID-19 restrictions but stopped short of a lockdown to stem the surging rate of infections, which are now averaging more than 10,000 per day.At a news conference in Brussels, Prime Minister Alexander De Croo announced, among other restrictions, fans are now banned from sports matches; zoos and theme parks will be closed; and limits will be placed on the number of people in cultural spaces. Teleworking remains the rule wherever possible.Belgium had already closed cafes, bars and restaurants and imposed a curfew, and has Europe’s …

United Nations Secretary General Antonio Guterres said it was very unfortunate that the 20 major industrialized nations did not come together in March, as he suggested then, to establish a coordinated response to suppress COVID-19 worldwide.In an interview with the Associated Press, Guterres said he hopes that as the G-20 summit is coming next month, the international community understand “they need to be much more coordinated in fighting the virus.”Guterres said the U.N. will be “strongly advocating” for a coordinated response to the disease, in addition to seeking a “guarantee” …

At a time when growing numbers of people are shunning vaccines, the polio vaccine proves that they work. As VOA’s Carol Pearson reports, despite setbacks and a coronavirus pandemic, the world is making headway in eliminating the crippling disease. …

October marks Pregnancy and Infant Loss Awareness Month in the US. It’s a topic not often talked about but something many couples go through, as Anush Avetisyan reports in this story narrated by Anna Rice. Camera: Anush Avetisyan …

U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV.The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut recovery time from 15 days to 10 on average in a large study led by the U.S. National Institutes of Health.It has been authorized for use on an emergency basis since spring, and it now becomes the first drug to win full Food and Drug Administration approval for treating COVID-19. President Donald Trump received it when he was …

Using blood of recovered COVID-19 patients, the so-called convalescent plasma, as a potential treatment is of little benefit in helping hospitalized patients fight off the infection, according to results of a clinical trial in India.Published in the BMJ (British Medical Journal) on Friday, the results show that convalescent plasma, which delivers antibodies from COVID-19 survivors to infected people, failed to reduce death rates or halt progression to severe disease.The findings, from a study of more than 400 hospitalized COVID-19 patients, are a setback for a treatment that U.S. President Donald …